IL6 and breast cancer: Knüpfer and Preiss revealed that higher IL-6 levels were significantly associated with tumour size, metastasis, stage, and decreased survival in colorectal cancer patients [34] and Ahmed et al. have demonstrated its association with tumour size in breast cancer patients [37].